200 Years in the making
For years, the vaginal speculum has been the same clunky, cold, painful, invasive device as when it was first invented nearly 200 years ago.
NOT ANYMORE.
Meet Nella, the first redesign of the speculum to put the patient and clinician experience first, emphasizing comfort and ease of use.
NELLA IS A GAME CHANGER
The Nella Difference
At Ceek Women's Health, we believe a human-centered design approach leads to products that improve gynecological care for all.
Our Ceek product line includes the Nella, a redesigned vaginal speculum built for patient comfort which comes in a reusable speculum and a disposable speculum, the VuSleeve, an innovative single-use sheath, and the VuLight, a single-use LED illuminator.
a Note From Founder, Fahti Khosrowshahi
“10 years ago, I was on my seventh round of fertility treatments and millionth internal pelvic exam - each one using clunky metal speculums that caused me pain, bleeding and soreness. I knew there had to be a better way.
After some research, I discovered that the traditional metal speculum is close to 200 years old. Despite innovation in our cell phones, no one has considered the most fundamental aspect of women’s health. From then on, my mission was to develop a speculum that places women at the center of the exam experience. Every design choice, every material, and every silhouette is created by women for women, putting comfort, ease, and design first. In 2015, I launched Ceek Women’s Health to create innovative solutions for the modern woman and the modern world we live in.”
EXECUTIVE TEAM
As the founder of Ceek, Fahti drives the research and development with her personal mission to transform women’s care. Fahti gained 15 years of experience at Campbell Alliance, the largest pure-play consulting firm focused in life sciences. As the account lead for two of Campbell’s largest accounts, she eventually led the Global Account Business Unit and ended her Campbell career as the Global Commercial Strategy Practice Area Lead.
Fahti is a graduate of Middlebury College and has a Master’s degree in Business from Vanderbilt University. She is a mom to two girls and is active with the not-for-profit organization Child Foundation.org.
Tracy is the Chief Medical Officer at Ceek Women’s Health and is responsible for Clinical, Medical, Regulatory and Quality. She was employee #2 and has been with the company since it started in 2017. Tracy has 23 Years of Women’s Health Medical Device Experience. She was @ Welch Allyn for 17 years where she commercialized dozens of products ran their Women’s Health Division. Tracy obtained her MD and BS in Health Science from Saba University School of Medicine and a BS in Marketing and International Studies from State University of New York @ Oswego. She resides in Skaneateles, NY with her husband Rob, and is the proud mom of Aidan (24), Ashton (20) and Torin (17). Tracy is active in her local community, loves to travel, spend time on Skaneateles Lake and plays golf and tennis.
Allison Loughlin, appointed as Chief Marketing Officer (CMO), joins Ceek from INNOVO where she was also the CMO. INNOVO is a femmtech startup that accelerated significant growth in the urinary incontinence space. Holding a Master’s from Columbia University, Allison has decades of experience in women’s brands including such legacy companies as Victoria’s Secret, Lilly Pulitzer, and Estee Lauder.
Sean joined Ceek Women’s Health in 2022 with a record of driving success in high-growth healthcareenvironments. Prior to Ceek, Sean was a Regional Vice President at Vein Clinics of America where he wasresponsible for scaling teams and improving efficiencies. Prior to acquisition by another healthcaregroup, Vein Clinics of America was a Private Equity-backed $300 Million specialty healthcare provider,operating 60 locations in 16 states, and impacting the lives of over 20,000 patients per year. Sean holds anMBA in Finance with a secondary emphasis in International Business, a Post-Graduate Certificate inExecutive Leadership, along with completing extensive prior medical coursework.
BOARD OF DIRECTORS
As the founder of Ceek, Fahti drives the research and development with her personal mission to transform women’s care. Fahti gained 15 years of experience at Campbell Alliance, the largest pure-play consulting firm focused in life sciences. As the account lead for two of Campbell’s largest accounts, she eventually led the Global Account Business Unit and ended her Campbell career as the Global Commercial Strategy Practice Area Lead.
Fahti is a graduate of Middlebury College and has a Master’s degree in Business from Vanderbilt University. She is a mom to two girls and is active with the not-for-profit organization Child Foundation.org.
Wendy White is an accomplished CEO and experienced private company corporate board directorvbringing expertise across growth, transformation, marketing strategy, risk management in the rare disease and the medical device industries.
An entrepreneur, Wendy founded and built Siren Interactive, a digital marketing agency in healthcare which was ultimately sold to Dohman Life Science (now Eversana) in 2014. She spent 15 years completing pioneering work in targeted social media outreach and patient-centered rare disease marketing.
Extensive contributor to the Board of the Healthcare Businesswomen’s Association (HBA) over 8 years including Chairman in 2015 growing membership to over 10,000 members. She took over as Interim chair of the organization from 2022-2023, stabilizing the workforce, the programs, and volunteers during a challenging transition from a “founding CEO”.
Strategic advisor for TREND community, the first company to use AI to turn the conversations of rare, chronic, and emerging disease communities into actionable insights. Chair of Global Genes, an $8M umbrella rare disease advocacy group, Wendy spearheaded the CEO succession plan and led a growth plan to transform the business to profitability.
Dr. Evantash has over two decades of experience working in medical and clinical affairs and brings a valuable clinical perspective to the Ceek Women’s Health board of directors. Dr. Evantash served as Medical Director and VP of Global Medical Affairs for Hologic and Chief Medical Officer for Alydia Health. After Alydia’s acquisition by Organon he co-founded BeSpoke Medical Affairs Solutions. Dr. Evantash received his medical degree from University of Pennsylvania School of Medicine as a Penn Scholar. He joined the faculty at Tufts University School of Medicine in Boston after finishing his residency at John Hopkins. At Tufts he was Division Chief of General Obstetrics and Gynecology.
David Pelizzon is a retired US Army officer who served almost 30 years on active duty in airborne and special operations units. Since his retirement from active duty in 2003, he has worked as a manufacturing executive in the US and Asia. Prior to starting Squadron Capital Mr. Pelizzon was the Managing Director of Precision Edge Holdings, Colson Associates in Chicago.
Currently he is the President of Squadron Capital, a firm that primarily manages direct investments in operating companies and that also invests in private equity funds and special situations in support of the long term investment objectives of a Chicago based trust.
Mr. Pelizzon is a graduate of the US Military Academy and has advanced degrees from Harvard University and the United States Naval War College.
Buket Grau is a healthcare executive with extensive experience in the biopharma, medical technology, and consumer health industries. She brings a successful record of launching and maximizing global brands and franchises across several therapeutic areas, contributing to a wide range of M&A and licensing deals, and leading enterprise strategy, portfolio optimization, separation and new business integration.
Ms. Grau currently serves as Head of Corporate Strategy, New Businesses, and Integration at Biogen. Previously at Biogen, Ms. Grau built and led the Early and External Product Commercialization function and served as Asset Executive across multiple franchises. Prior to Biogen, Ms. Grau held global and international commercial strategy and operations leadership roles at Stryker Corporation, Procter & Gamble, Citigroup, and Dogus Group.
Ms. Grau currently serves on the Board of Directors at Ceek Women’s Health company, and she is an advisor at the Termeer Institute focused on supporting life science leaders to advance groundbreaking, patient-centered solutions. She is Chair Emeritus and previously President and member of the Board of Directors of the Healthcare Businesswomen’s Association (HBA) and President of the HBA Boston Chapter. Earlier in her career, she was also involved in several non-profit organizations focused on environmental protection and education.
Ms. Grau earned her B.S. in Biological Sciences from Orta Doğu Technical University, received her Medical Devices Regulatory Affairs Certificate from the Regulatory Affairs Professional Society, and completed the Executive Marketing Program at the Kellogg School of Management and the Executive Leadership Program at Harvard Business School.
